Growth and differentiation factor-9 promotes adhesive and motile capacity of prostate cancer cells by up-regulating FAK and Paxillin via Smad dependent pathway

Oncology Reports

Volumn 24, Issue 6, 2010, Pages 1653-1659

  Bokobza, Sivan M ^a   Ye, Lin ^a   Kynaston, Howard G ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bone morphogenetic protein; FAK; GDF 9; Motility; Prostate cancer

Indexed keywords

ACTIN; BONE MORPHOGENETIC PROTEIN; FOCAL ADHESION KINASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GROWTH DIFFERENTIATION FACTOR 9; PAXILLIN; RECOMBINANT GROWTH AND DIFFERENTIATION FACTOR 9; RECOMBINANT PROTEIN; RIBOZYME; SMAD PROTEIN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; BONE METASTASIS; BONE REMODELING; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL MOTILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENE; UPREGULATION;

EID: 78649441329     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00001030     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Ye L, Lewis-Russell JM, Kyanaston HG and Jiang WG: Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histol Histopathol 22: 1129-1147, 2007. (Pubitemid 47470307)
3. Chen D, Zhao M and Mundy GR: Bone morphogenetic proteins. Growth Factors 22: 233-241, 2004.
4. Shi Y and Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700, 2003.
5. Nohe A, Hassel S, Ehrlich M, et al: The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277: 5330-5338, 2002.
6. Bobinac D, Maric I, Zoricic S, et al: Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Croat Med J 46: 389-396, 2005.
7. Ye L, Kynaston H and Jiang WG: Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4. Mol Cancer Res 6: 1594-1606, 2008.
8. Aaltonen J, Laitinen MP, Vuojolainen K, et al: Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J Clin Endocrinol Metab 84: 2744-2750, 1999.
9. Jiang WG, Hiscox S, Hallett MB, Scott C, Horrobin DF and Puntis MC: Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. Br J Cancer 71: 744-752, 1995.
10. Mazerbourg S, Klein C, Roh J, et al: Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol Endocrinol 18: 653-665, 2004.
11. Laitinen M, Vuojolainen K, Jaatinen R, et al: A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis. Mech Dev 78: 135-140, 1998.
12. Hanavadi S, Martin TA, Watkins G, Mansel RE and Jiang WG: The role of growth differentiation factor-9 (GDF-9) and its analog, GDF-9b/BMP-15, in human breast cancer. Ann Surg Oncol 14: 2159-2166, 2007.
13. Ma LL, Sun WJ, Wang Z, Zh GY, Li P and Fu SB: Effects of silencing of mutant p53 gene in human lung adenocarcinoma cell line Anip973. J Exp Clin Cancer Res 25: 585-592, 2006. (Pubitemid 46166773)
14. Zhuang Z, Jian P, Longjiang L, Bo H and Wenlin X: Oral cancer cells with different potential of lymphatic metastasis displayed distinct biologic behaviors and gene expression profiles. J Oral Pathol Med 39: 168-175, 2010.
15. Brakebusch C and Fassler R: The integrin-actin connection, an eternal love affair. EMBO J 22: 2324-2333, 2003.
16. Mitra SK, Hanson DA and Schlaepfer DD: Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6: 56-68, 2005.
17. Turner CE: Paxillin. Int J Biochem Cell Biol 30: 955-959, 1998.
18. Vinall RL, Lo SH and Reddi AH: Regulation of articular chondrocyte phenotype by bone morphogenetic protein 7, interleukin 1, and cellular context is dependent on the cytoskeleton. Exp Cell Res 272: 32-44, 2002.
19. Ye L, Lewis-Russell JM, Kynaston H and Jiang WG: Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists. J Urol 178: 1086-1091, 2007.
20. Ye L, Kynaston H and Jiang WG: Bone morphogenetic protein-10 suppresses the growth and aggressiveness of prostate cancer cells through a Smad-independent pathway. J Urol 181: 2749-2759, 2009.